We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · January 20, 2021

Real-World Data on Subcutaneous vs Oral Methotrexate in Psoriasis

The British Journal of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The British Journal of Dermatology
The Value of Subcutaneous vs. Oral Methotrexate: Real-World Data From the German Psoriasis Registry PsoBest
Br J Dermatol 2020 Nov 21;[EPub Ahead of Print], K Reich, C Sorbe, L Griese, JLK Reich, M Augustin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading